MACM
March Altus Capital Management Portfolio holdings
AUM
$16M
1-Year Return
18.92%
This Quarter Return
+7.76%
1 Year Return
+18.92%
3 Year Return
+153.93%
5 Year Return
–
10 Year Return
–
AUM
$311M
AUM Growth
-$18.7M
(-5.7%)
Cap. Flow
-$32.3M
Cap. Flow
% of AUM
-10.36%
Top 10 Holdings %
Top 10 Hldgs %
51.43%
Holding
37
New
9
Increased
4
Reduced
13
Closed
9
Top Buys
| 1 |
United Therapeutics
UTHR
|
+$15.7M |
| 2 |
Insulet
PODD
|
+$12.8M |
| 3 |
Biogen
BIIB
|
+$11.3M |
| 4 |
Zoetis
ZTS
|
+$10.4M |
| 5 |
Incyte
INCY
|
+$9.75M |
Top Sells
| 1 |
Aon
AON
|
+$12.3M |
| 2 |
Baxter International
BAX
|
+$12.1M |
| 3 |
Humana
HUM
|
+$11.6M |
| 4 |
eHealth
EHTH
|
+$11.3M |
| 5 |
Perrigo
PRGO
|
+$11.2M |
Sector Composition
| 1 | Healthcare | 84.92% |
| 2 | Materials | 5.92% |
| 3 | Industrials | 4.21% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DexCom
DXCM
$29.9B
| $28.9M | 9.28% |
2,795,340
-544,012
| -16% | -$5.63M |
|
2
Alkermes
ALKS
$4.45B
| $20.4M | 6.55% |
462,853
| – | – |
|
|
MON
3
DELISTED
Monsanto Co
MON
| $18.4M | 5.92% |
162,131
-36,857
| -19% | -$4.19M |
|
4
Eli Lilly
LLY
$677B
| $15.8M | 5.07% |
268,087
+41,249
| +18% | +$2.43M |
|
|
5
United Therapeutics
UTHR
$18.3B
| $15.7M | 5.03% |
+166,725
| New | +$15.7M |
|
|
ATHN
6
DELISTED
Athenahealth, Inc.
ATHN
| $13.1M | 4.21% |
81,916
+15,690
| +24% | +$2.51M |
|
|
7
Insulet
PODD
$24.1B
| $12.8M | 4.12% |
+270,717
| New | +$12.8M |
|
|
AGN
8
DELISTED
ALLERGAN INC
AGN
| $12M | 3.85% |
96,627
-9,018
| -9% | -$1.12M |
|
|
MNK
9
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $11.5M | 3.7% |
181,966
-39,119
| -18% | -$2.48M |
|
|
ZLTQ
10
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $11.5M | 3.69% |
586,065
-170,440
| -23% | -$3.34M |
|
|
11
Biogen
BIIB
$21.2B
| $11.3M | 3.63% |
+36,976
| New | +$11.3M |
|
|
ALXN
12
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $11.3M | 3.62% |
74,111
-17,300
| -19% | -$2.63M |
|
|
13
Zoetis
ZTS
$65.7B
| $10.4M | 3.35% |
+360,761
| New | +$10.4M |
|
14
Universal Health Services
UHS
$12.2B
| $10.2M | 3.26% |
123,759
-20,747
| -14% | -$1.7M |
|
15
HCA Healthcare
HCA
$94.8B
| $10.1M | 3.26% |
193,226
-174,164
| -47% | -$9.14M |
|
|
16
Incyte
INCY
$16.2B
| $9.75M | 3.13% |
+182,192
| New | +$9.75M |
|
|
CYBX
17
DELISTED
CYBERONICS INC
CYBX
| $9.31M | 2.99% |
142,636
-24,252
| -15% | -$1.58M |
|
18
West Pharmaceutical
WST
$18.2B
| $9.2M | 2.95% |
208,801
-128,360
| -38% | -$5.65M |
|
|
LMNX
19
DELISTED
Luminex Corp
LMNX
| $9.09M | 2.92% |
+501,923
| New | +$9.09M |
|
20
Tandem Diabetes Care
TNDM
$829M
| $8.14M | 2.61% |
36,826
-5,976
| -14% | -$1.32M |
|
|
UNIS
21
DELISTED
Unilife Corporation
UNIS
| $7.57M | 2.43% |
185,919
+18,176
| +11% | +$740K |
|
|
ENZY
22
DELISTED
Enzymotec Ltd
ENZY
| $7.22M | 2.32% |
327,962
+125,000
| +62% | +$2.75M |
|
23
Encompass Health
EHC
$12.7B
| $6.92M | 2.22% |
242,147
-155,646
| -39% | -$4.45M |
|
24
Accuray
ARAY
$177M
| $6.59M | 2.12% |
686,569
| – | – |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $6.29M | 2.02% |
+163,675
| New | +$6.29M |
|